Personalized treatment often starts with genetic testing of the cancer cells. This can involve sequencing the DNA of the tumor to identify specific mutations or biomarkers. Other factors, such as the patient’s lifestyle, family history, and response to previous treatments, are also considered. Advanced technologies like Next-Generation Sequencing (NGS) and liquid biopsies are frequently used for this purpose.
